Analysts expect IAC to sweeten Angie’s List bid
After seeing its offers to buy Angie’s List turned down in private and in public, New York-based IAC/InterActiveCorp has the next move in what is shaping up as a chess match between the two firms.
Public Companies
Articles
Aggressive bidder has Angie’s List over a barrel, analysts say
Internet behemoth IAC appears bent on hashing out an acquisition and likely would stage a hostile takeover if Angie’s List resists, market analysts say.
Simon raises quarterly dividend, full-year forecast
A strong third quarter prompted Simon to boost its earnings forecast and raise its quarterly dividend to $1.60 per share, a 23.1 percent year-over-year increase.
Dow AgroSciences up for sale or spin-off, again
Dow Chemical is exploring all options for its subsidiary, Indianapolis-based Dow AgroSciences. The company employs 1,500 workers in the Indianapolis area and, as a stand-alone firm, would be the fifth-largest by revenue in Indiana.
Angie’s List ekes out profit as new CEO rebuffs activist
Shares sank 15 percent on Wednesday morning despite an $82,000 profit in the third quarter. New CEO Scott Durchslag told analysts he wanted to increase shareholder value organically rather than pursue a sale or merger.
Q&A: HHGregg CEO talks turnaround strategy
Dennis May has been at the helm of the electronics and appliance retailer since 2010 and has seen sales of televisions swoon. But expanding into furniture and high-end appliances might help right the ship.
Angie’s List restructuring its 1,000-person sales force
The firm is aiming to boost revenue with the biggest reorganization of its sales force in its 20-year history. But some salespeople fear the changes will cut their compensation.
Finish Line clocks steady performance in second quarter
The Indianapolis-based retailer of athletic apparel reported profit in its fiscal second quarter of $25.9 million, slightly down from the same quarter a year ago.
Hedge fund ups Angie’s List holdings again, seeks board seats
Now with a 9-percent stake, New York-based TCS Capital Management says it’s after multiple board seats and plans to continue discussing options to maximize the firm’s value, including a sale.
S&P takes significant hit amid global stock rout
The Standard & Poor’s 500 Index fell into a correction Monday for the first time since 2011 in one of the most volatile trading days ever, as a rout in global equity markets deepened.
Market plunge driven by fearful investors fizzles in U.S.
A wave of fear triggered by instability in China initially doused U.S. stocks on Monday morning, but then quickly receded by noon.
Allegion adds technology, products, jobs through acquisitions
The company makes entry doors and security products that almost everyone has used but the company remains not that well known.
Noble Roman’s making strides on take-and-bake biz
The Indianapolis-based company in the past two months has increased its supermarket presence and hired an executive to oversee grocery operations, while securing more financing to help achieve the growth.
HHGregg’s latest loss still beats Wall Street expectations
The retailer reported another lackluster quarter with sales dips in every category except home products. But its shares shot up in trading because the results were better than expected.
Simon sees jump in cash flow, sunny skies ahead
Simon Property Group Inc., the largest U.S. mall owner, on Friday reported a 22-percent jump in second-quarter funds from operations and increased its full-year forecast as rising employment helps lure shoppers.
Dow Agro sees sales fall as ag market stalls
Sales at Dow AgroSciences LLC fell in the second quarter due to lower demand in the Americas and a stronger U.S. dollar. Dow’s profits, however, rose 8 percent due to cost-cutting and the sale of one product line.
Reports: Blockbuster Anthem-Cigna deal for $48B imminent
Reports by the Wall Street Journal, Bloomberg News and Reuters said Indianapolis-based Anthem has offered $48 billion for Cigna Corp.—which would be the largest merger in health insurance history.
Lilly posts lackluster profit but boosts full-year forecast
Eli Lilly and Co.’s profits plunged 18 percent in the second-quarter but still easily beat the lowered expectations of Wall Street analysts.
Alzheimer’s trials offer little certainty for investors, patients
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
Angie’s List exec takes over as interim CEO as Oesterle exits
Longtime Angie’s List Inc. CEO Bill Oesterle has officially resigned from the company while COO Mark Howell takes the reins during the search for a permanent successor.